标题
An overview of glutaminyl cyclase inhibitors for Alzheimer’s disease
作者
关键词
-
出版物
Future Medicinal Chemistry
Volume 11, Issue 24, Pages 3179-3194
出版商
Future Science Ltd
发表日期
2019-12-16
DOI
10.4155/fmc-2019-0163
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A critical appraisal of amyloid-β-targeting therapies for Alzheimer disease
- (2019) Francesco Panza et al. Nature Reviews Neurology
- Potent human glutaminyl cyclase inhibitors as potential anti-Alzheimer’s agents: Structure-activity relationship study of Arg-mimetic region
- (2018) Van T.H. Ngo et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Structure-activity relationship investigation of Phe-Arg mimetic region of human glutaminyl cyclase inhibitors
- (2018) Van T.H. Ngo et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Immunohistochemical Evidence from APP-Transgenic Mice for Glutaminyl Cyclase as Drug Target to Diminish pE-Abeta Formation
- (2018) Maike Hartlage-Rübsamen et al. MOLECULES
- Concerted action of dipeptidyl peptidase IV and glutaminyl cyclase results in formation of pyroglutamate-modified amyloid peptides in vitro
- (2018) Alvard Antonyan et al. NEUROCHEMISTRY INTERNATIONAL
- Highlights in BACE1 Inhibitors for Alzheimer's Disease Treatment
- (2018) Judite R. M. Coimbra et al. Frontiers in Chemistry
- Pyroglutamate and Isoaspartate modified Amyloid-Beta in ageing and Alzheimer’s disease
- (2018) Maria Luisa Moro et al. Acta Neuropathologica Communications
- Identifying hQC Inhibitors of Alzheimer’s Disease by Effective Customized Pharmacophore-Based Virtual Screening, Molecular Dynamic Simulation, and Binding Free Energy Analysis
- (2018) Weicong Lin et al. APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY
- Glutaminyl Cyclase in Human Cortex: Correlation with (pGlu)-Amyloid-β Load and Cognitive Decline in Alzheimer's Disease
- (2018) Markus Morawski et al. JOURNAL OF ALZHEIMERS DISEASE
- Comprehensive review of mechanisms of pathogenesis involved in Alzheimer’s disease and potential therapeutic strategies
- (2018) Piyoosh Sharma et al. PROGRESS IN NEUROBIOLOGY
- Safety, tolerability and efficacy of the glutaminyl cyclase inhibitor PQ912 in Alzheimer’s disease: results of a randomized, double-blind, placebo-controlled phase 2a study
- (2018) Philip Scheltens et al. Alzheimers Research & Therapy
- Can small molecule inhibitors of glutaminyl cyclase be used as a therapeutic for Alzheimer's disease?
- (2017) Haiqiang Wu Future Medicinal Chemistry
- Synthesis and Evaluation of Diphenyl Conjugated Imidazole Derivatives as Potential Glutaminyl Cyclase Inhibitors for Treatment of Alzheimer’s Disease
- (2017) Manman Li et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Potent Human Glutaminyl Cyclase Inhibitors as Anti-Alzheimer’s Agents Based on Rational Design
- (2017) Van-Hai Hoang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Glutaminyl Cyclase Inhibitor PQ912 Improves Cognition in Mouse Models of Alzheimer’s Disease—Studies on Relation to Effective Target Occupancy
- (2017) Torsten Hoffmann et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Identification of potential glutaminyl cyclase inhibitors from lead-like libraries by in silico and in vitro fragment-based screening
- (2017) Mária Szaszkó et al. MOLECULAR DIVERSITY
- Glutaminyl cyclase activity correlates with levels of Aβ peptides and mediators of angiogenesis in cerebrospinal fluid of Alzheimer’s disease patients
- (2017) Claire Bridel et al. Alzheimers Research & Therapy
- Inhibitory effect of flavonoids on human glutaminyl cyclase
- (2016) Manman Li et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Natural Products from Microalgae with Potential against Alzheimer’s Disease: Sulfolipids Are Potent Glutaminyl Cyclase Inhibitors
- (2016) Stephanie Hielscher-Michael et al. Marine Drugs
- siRNA screen identifies QPCT as a druggable target for Huntington's disease
- (2015) Maria Jimenez-Sanchez et al. Nature Chemical Biology
- Cortical pyroglutamate amyloid-β levels and cognitive decline in Alzheimer's disease
- (2015) Violetta N. Pivtoraiko et al. NEUROBIOLOGY OF AGING
- Oleuropein aglycone protects against pyroglutamylated-3 amyloid-ß toxicity: biochemical, epigenetic and functional correlates
- (2015) Ilaria Luccarini et al. NEUROBIOLOGY OF AGING
- Neuropathology and biochemistry of Aβ and its aggregates in Alzheimer’s disease
- (2014) Dietmar Rudolf Thal et al. ACTA NEUROPATHOLOGICA
- Pyroglutamylated amyloid-β is associated with hyperphosphorylated tau and severity of Alzheimer’s disease
- (2014) Markus Mandler et al. ACTA NEUROPATHOLOGICA
- Increased glutaminyl cyclase expression in peripheral blood of Alzheimer's disease patients
- (2014) Silvia Bolognin et al. Alzheimers & Dementia
- Biochemical stages of amyloid-β peptide aggregation and accumulation in the human brain and their association with symptomatic and pathologically preclinical Alzheimer’s disease
- (2014) Ajeet Rijal Upadhaya et al. BRAIN
- Pyroglutamate-3 Amyloid-β Deposition in the Brains of Humans, Non-Human Primates, Canines, and Alzheimer Disease–Like Transgenic Mouse Models
- (2013) Jeffrey L. Frost et al. AMERICAN JOURNAL OF PATHOLOGY
- Structure–activity relationship of human glutaminyl cyclase inhibitors having an N-(5-methyl-1H-imidazol-1-yl)propyl thiourea template
- (2013) Phuong-Thao Tran et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Structure–Activity Relationships of Benzimidazole-Based Glutaminyl Cyclase Inhibitors Featuring a Heteroaryl Scaffold
- (2013) Daniel Ramsbeck et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Polyphenol Oleuropein Aglycone Protects TgCRND8 Mice against Aß Plaque Pathology
- (2013) Cristina Grossi et al. PLoS One
- CP-MLR/PLS directed QSAR study on the glutaminyl cyclase inhibitory activity of imidazoles: rationales to advance the understanding of activity profile
- (2012) Viney Kumar et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- The isoenzyme of glutaminyl cyclase is an important regulator of monocyte infiltration under inflammatory conditions
- (2011) Holger Cynis et al. EMBO Molecular Medicine
- Selective Hippocampal Neurodegeneration in Transgenic Mice Expressing Small Amounts of Truncated A Is Induced by Pyroglutamate-A Formation
- (2011) A. Alexandru et al. JOURNAL OF NEUROSCIENCE
- Pyroglutamate Formation Influences Solubility and Amyloidogenicity of Amyloid Peptides
- (2009) Dagmar Schlenzig et al. BIOCHEMISTRY
- Inhibitors for Human Glutaminyl Cyclase by Structure Based Design and Bioisosteric Replacement
- (2009) Mirko Buchholz et al. JOURNAL OF MEDICINAL CHEMISTRY
- Systemic inflammation and disease progression in Alzheimer disease
- (2009) C. Holmes et al. NEUROLOGY
- A conserved hydrogen-bond network in the catalytic centre of animal glutaminyl cyclases is critical for catalysis
- (2008) Kai-Fa Huang et al. BIOCHEMICAL JOURNAL
- Inhibition of glutaminyl cyclase prevents pGlu-A formation after intracorticalhippocampal microinjectionin vivoin situ
- (2008) Stephan Schilling et al. JOURNAL OF NEUROCHEMISTRY
- Glutaminyl cyclase inhibition attenuates pyroglutamate Aβ and Alzheimer's disease–like pathology
- (2008) Stephan Schilling et al. NATURE MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now